NCT01746420 - Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

December 12, 2012

Primary Completion Date

October 21, 2014

Study Completion Date

October 21, 2014

Conditions

Lateral Epicondylitis

Interventions

DRUG

rhPDGF-BB Injection

Comparison of placebo control (0 mg rhPDGF-BB) and different dosages (0.45, 0.75, 1.5, and 3.0 mg) of rhPDGF-BB Injection administered through a one-time injection

DRUG

Placebo

sodium acetate buffer (0 mg rhPDGF-BB)

Trial Locations (6)

28207

OrthoCarolina, Charlotte

33637

Foundation for Orthopaedic Research and Education, Tampa

34209

Coastal Orthopedics & Sports Medicine, Bradenton

72401

NEA Baptist Clinic, Jonesboro

85023

Arizona Research Center, Phoenix

85712

Tucson Orthopaedic Institute, Tucson